©The Author(s) 2025.
World J Stem Cells. Oct 26, 2025; 17(10): 110248
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.110248
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.110248
Table 2 Preclinical Strategies of adipose-derived stem cell-derived extracellular vesicles in osteoarthritis
| Pretreated cells/modified EVs | Strategy | In vivo model | Delivery route | Effects in vivo | Ref. |
| ADSCs stimulated with ↓TNF-α & IFN-γ to ADSC-EVs | MiR-27b-3p enriched EVs + SF scaffold | Rabbit TMJ condylar defect | Scaffold implantation | ↑BMSC proliferation, osteo-/chondrogenesis; ↑M2 macrophages; ↓inflammation; ↑bone/cartilage repair | [22] |
| PEMF-stimulated rat ADSC-EVs | PEMF stimulation (15-75 Hz) to enhance EVs | ACLT rat OA model | IA injection (40 μL, weekly × 4) | ↑Anabolic cartilage markers; ↓MMP-13, IL-1β; ↑histology scores; ↓inflammation | [23] |
| ADSC-EVs enriched with miR-486-5p (miR-486-5p mimic-transfected ADSCs) | Engineered EVs delivering miR-486-5p | DMM rat OA model | IA injection (20 μL, weekly × 10) | ↓Chondrocyte apoptosis, MMP-13, inflammation; ↑COL II, cartilage matrix; ↓OARSI score | [24] |
| Curcumin-loaded ADSC-EVs | Drug-loading to enhance antioxidant & anti-apoptosis | ACLT mouse model | IA injection (10 μL, biweekly × 4) | ↓Cartilage degeneration, oxidative stress, apoptosis, pain; ↑ECM components (COL II, aggrecan) | [27] |
| ADSC-EVs enriched with miR-376c-3p | MiR-376c-3p delivery targeting WNT/β-catenin | MIA rat OA model | IA injection (100 μg EVs, single dose) | ↓Cartilage degradation, fibrosis, inflammatory cytokines; ↑COL II; WNT signaling inhibition | [90] |
| ADSC-EVs (unmodified) | Native EVs isolated by TFF | MIA-induced rat OA model | IA injection (30 μL, weekly × 3 or 6) | ↓Mankin score, cartilage erosion, inflammatory markers; ↑cartilage matrix protection | [91] |
| ADSC-EVs (unmodified) | Native EVs isolated by TFF | DMM mouse OA model | IA injection (6 μL, weekly × 6) | ↓OARSI score, synovial inflammation, M1 macrophages; ↑COL II, chondrocyte proliferation/migration | [91] |
- Citation: Lin A, Yu JL, Yuan SM, Tang YF, Yang KX, Wang YH, Huo FJ, Jin ZR, Xiao Q, Yang C, Tian WD. Extracellular vesicles from adipose-derived stem cells in bone regeneration: Mechanisms and therapeutic advances. World J Stem Cells 2025; 17(10): 110248
- URL: https://www.wjgnet.com/1948-0210/full/v17/i10/110248.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i10.110248